USD 20.21
(-4.13%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -17.88 Million | -74.26 Million | 85.29 Million | 10.36 Million | -72.46 Million |
Net Income | -75.26 Million | -102.19 Million | -78.18 Million | -41.02 Million | -77.21 Million |
Depreciation & Amortization | 19.28 Million | 11.37 Million | 8.75 Million | 7.24 Million | 1.83 Million |
Deferred income taxes | 10.92 Million | - | 4.96 Million | 5.18 Million | 2.8 Million |
Stock-based compensation | 49.64 Million | 39.32 Million | 23.22 Million | 5.7 Million | 998 Thousand |
Change in working capital | -21.01 Million | -33.76 Million | 125.88 Million | 35.42 Million | -1.3 Million |
Other non-cash items | -1.46 Million | 10.99 Million | 656 Thousand | -2.16 Million | 424 Thousand |
Investing Cash Flow | -110.97 Million | -283.89 Million | -129.26 Million | -19.67 Million | -24.68 Million |
Investments in PPE | -28.17 Million | -23.39 Million | -14.02 Million | -8.88 Million | -6.59 Million |
Acquisitions | -29.62 Million | -19.82 Million | -64.5 Million | -5.5 Million | -14.83 Million |
Investment purchases | -146.03 Million | -269.67 Million | -13.78 Million | - | - |
Sales/Maturities of investments | 138.12 Million | 66.99 Million | -11.46 Million | - | - |
Other Investing Activities | -45.27 Million | -37.98 Million | -25.49 Million | -5.28 Million | -3.25 Million |
Financing Cash Flow | 30.63 Million | 72.93 Million | 376.24 Million | 60.75 Million | 161.52 Million |
Debt repayment | -380.5 Million | -200 Million | -12.21 Million | -1.98 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | -16.02 Million | -5.45 Million | -2.76 Million | - | - |
Common Stock Issuance | 7.32 Million | 1.21 Million | 385.73 Million | 56.82 Million | 162.47 Million |
Other Financing Activities | 403.8 Million | 277.18 Million | 5.49 Million | 5.91 Million | -947 Thousand |
Accounts receivables | 14.4 Million | 47.17 Million | -120.15 Million | -29.22 Million | -51.95 Million |
Accounts payables | -34.61 Million | -73.25 Million | 242.85 Million | 66.21 Million | 46.4 Million |
Inventory | - | - | 1.58 Million | -745 Thousand | 2.76 Million |
Other working capital | -810 Thousand | -7.67 Million | 1.59 Million | -825 Thousand | 1.47 Million |
Cash at beginning of period | 280.75 Million | 565.99 Million | 233.72 Million | 182.27 Million | 117.89 Million |
Cash at end of period | 182.57 Million | 280.75 Million | 565.99 Million | 233.72 Million | 182.27 Million |
Capital Expenditure | -28.17 Million | -23.39 Million | -14.02 Million | -8.88 Million | -6.59 Million |
Effect of forex changes on cash | 43 Thousand | -21 Thousand | - | - | - |
Net cash flow / Change in cash | -98.18 Million | -285.24 Million | 332.26 Million | 51.45 Million | 64.38 Million |
Free Cash Flow | -46.05 Million | -97.65 Million | 71.26 Million | 1.48 Million | -79.05 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -17.06 Million | -20.47 Million | -23.24 Million | -75.26 Million | -18.23 Million | -15.58 Million |
Depreciation & Amortization | 8.88 Million | 7.8 Million | 6.87 Million | 19.28 Million | 5.08 Million | 3.92 Million |
Deferred income taxes | - | - | -6.35 Million | 10.92 Million | 2.72 Million | 3.63 Million |
Stock-based compensation | 14.96 Million | 14.83 Million | 13.38 Million | 49.64 Million | 12.85 Million | 11.9 Million |
Change in working capital | -4.98 Million | 38.36 Million | -25.22 Million | -21.01 Million | -16.97 Million | -23.23 Million |
Other non-cash items | 51.5 Million | -1.65 Million | 8.05 Million | -1.46 Million | -197 Thousand | -273 Thousand |
Investing Cash Flow | 16.94 Million | -20.94 Million | -24.79 Million | -110.97 Million | -27.03 Million | -35.27 Million |
Investments in PPE | -9.13 Million | -8.58 Million | -7.33 Million | -28.17 Million | -7.13 Million | -8.49 Million |
Acquisitions | -46.75 Million | -108.45 Million | -974 Thousand | -29.62 Million | -16.64 Million | -12 Million |
Investment purchases | -18.7 Million | -2.9 Million | -29.99 Million | -146.03 Million | -27.97 Million | -52.45 Million |
Sales/Maturities of investments | 92.34 Million | 100.05 Million | 27.78 Million | 138.12 Million | 33.44 Million | 32.54 Million |
Other Investing Activities | -804 Thousand | -1.04 Million | -14.28 Million | -45.27 Million | -8.72 Million | 5.14 Million |
Financing Cash Flow | -16.31 Million | 5.28 Million | 7.58 Million | 30.63 Million | -3.91 Million | 9.68 Million |
Debt repayment | -16.7 Million | -10 Million | -105 Million | -380.5 Million | -105 Million | -95.5 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -6.02 Million | -7.09 Million | -4.74 Million | -16.02 Million | -4.64 Million | -3.01 Million |
Common Stock Issuance | 6.4 Million | 2.4 Million | -899 Thousand | 7.32 Million | 802 Thousand | 3.2 Million |
Other Financing Activities | -6.02 Million | -7.11 Million | 113.48 Million | 403.8 Million | 104.92 Million | 105 Million |
Accounts receivables | 14.51 Million | -33.67 Million | 3.41 Million | 14.4 Million | -16.11 Million | 48.58 Million |
Accounts payables | -30.57 Million | 68.21 Million | -32.06 Million | -34.61 Million | 6.53 Million | -71.83 Million |
Inventory | - | - | -810 Thousand | - | - | - |
Other working capital | 11.07 Million | 3.82 Million | 4.24 Million | -810 Thousand | -7.39 Million | 17 Thousand |
Cash at beginning of period | 209.84 Million | 182.57 Million | 226.23 Million | 280.75 Million | 271.94 Million | 317.14 Million |
Cash at end of period | 214.97 Million | 209.84 Million | 182.57 Million | 182.57 Million | 226.23 Million | 271.94 Million |
Capital Expenditure | -9.13 Million | -8.58 Million | -7.33 Million | -28.17 Million | -7.13 Million | -8.49 Million |
Effect of forex changes on cash | -19 Thousand | -49 Thousand | 48 Thousand | 43 Thousand | -12 Thousand | 4000.00 |
Net cash flow / Change in cash | 5.12 Million | 27.27 Million | -43.66 Million | -98.18 Million | -45.71 Million | -45.2 Million |
Free Cash Flow | -4.62 Million | 34.38 Million | -33.82 Million | -46.05 Million | -21.87 Million | -28.12 Million |
TITANBIO
PML
002669
RHHVF
2605
CNK